NICHOLAS STEIER: Open Payments
NPI 1174673172 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 24 payments from 12 companies in 2025. Trend: 2023 $313 · 2024 $298 · 2025 $420
Food & beverage: $404Education: $16
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Amgen Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| PFIZER INC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: MOUNJARO, CAPLYTA, JARDIANCE, Ozempic, Cologuard Collection Kit, EVENITY, Kerendia, VYNDAMAX.
Industry payments across NE — which companies pay providers there.
